Oxford, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of small molecule therapeutics designed for weight loss with muscle preservation in obesity-related and cardiometabolic conditions. MitoRx Therapeutics is based in Oxford, United Kingdom and was founded in 2021. Its last reported valuation was $31.4 million in Nov 2025. It has raised $17.5 million.
Last reported valuation
$31.4M
Oct 2026
Priced at
—
Total raised
$17.5M
Last round
—
Team — not yet on record
No current team members for MitoRx Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MitoRx Therapeutics with a free account
·The complete investor list: 13 names
·Watch MitoRx Therapeutics: the Monday email on marks, rounds and moves
